Sight Sciences (SGHT) Income from Continuing Operations (2020 - 2026)

Sight Sciences' (SGHT) quarterly Income from Continuing Operations came in at 12980000.0 in Q1 2026, up 8.29% year-on-year from 11985837.68 in Q1 2025, and down 211.87% quarter-over-quarter from 4162000.0 in Q4 2025.

Sight Sciences (SGHT) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Sight Sciences' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 12980000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 8.29% year-over-year to 12980000.0 in Q1 2026; TTM through Mar 2026 was 37252000.0, a 24.58% increase from a year earlier, with the FY2025 full-year figure at 38426000.0, up 25.4% from the prior year.
  • Income from Continuing Operations declined to 12980000.0 in Q1 2026 per SGHT's latest filing, from 4162000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 4162000.0 in Q4 2025 and bottomed at 23843000.0 in Q2 2022.
  • The 5-year median for Income from Continuing Operations is 13035000.0 (2023), against an average of 14394235.29.
  • Across the five-year window, Income from Continuing Operations slumped 90.06% in 2022 and soared 64.87% in 2025, its largest moves.
  • Year by year, Income from Continuing Operations stood at 16907000.0 in 2022, then soared by 36.77% to 10691000.0 in 2023, then fell by 10.8% to 11846000.0 in 2024, then surged by 64.87% to 4162000.0 in 2025, then sank by 211.87% to 12980000.0 in 2026.
  • Per Business Quant, the three latest SGHT Income from Continuing Operations figures stand at 12980000.0 (Q1 2026), 4162000.0 (Q4 2025), and 8169000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Sight Sciences 253.53 Mn 168.57 Mn 16.98 Mn -12.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.98 Mn
Dec 31, 2025 -4.16 Mn
Sep 30, 2025 -8.17 Mn
Jun 30, 2025 -11.94 Mn
Mar 31, 2025 -14.15 Mn
Dec 31, 2024 -11.85 Mn
Sep 30, 2024 -11.07 Mn
Jun 30, 2024 -12.33 Mn
Mar 31, 2024 -16.27 Mn
Dec 31, 2023 -10.69 Mn
Sep 30, 2023 -13.04 Mn
Jun 30, 2023 -14.75 Mn
Mar 31, 2023 -17.07 Mn
Dec 31, 2022 -16.91 Mn
Sep 30, 2022 -22.23 Mn
Jun 30, 2022 -23.84 Mn
Mar 31, 2022 -23.26 Mn
Dec 31, 2021 -15.94 Mn
Sep 30, 2021 -17.17 Mn
Jun 30, 2021 -17.62 Mn